We are live on ! Find out more
JWBC

J.W. Burns & Co Portfolio holdings

AUM $959M
1-Year Est. Return 25.08%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+25.08%
3 Year Est. Return
+78.47%
5 Year Est. Return
+103.81%
10 Year Est. Return
+394.19%
AUM
$301M
AUM Growth
+$18.9M
Cap. Flow
+$8.33M
Cap. Flow %
2.77%
Top 10 Hldgs %
29.97%
Holding
160
New
11
Increased
64
Reduced
59
Closed
1

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$724K
2
MCD icon
McDonald's
MCD
+$723K
3
IBB icon
iShares Biotechnology ETF
IBB
+$177K
4
BMY icon
Bristol-Myers Squibb
BMY
+$168K
5
MSFT icon
Microsoft
MSFT
+$166K

Sector Composition

Rank Sector Weight
1 Healthcare 14.16%
2 Consumer Staples 13.19%
3 Technology 12.44%
4 Industrials 12.35%
5 Miscellaneous 11.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
26
Altria Group
MO
$115B
$3.5M 1.16%
83,469
-796
-0.9% -$32K
JPM icon
27
JPMorgan Chase
JPM
$951B
$3.39M 1.13%
58,774
+3,762
+7% +$212K
KO icon
28
Coca-Cola
KO
$386B
$3.37M 1.12%
79,508
+2,083
+3% +$84.5K
F icon
29
Ford
F
$55.3B
$3.36M 1.12%
194,816
+13,407
+7% +$218K
BRK.B icon
30
Berkshire Hathaway Class B
BRK.B
$1.08T
$3.29M 1.09%
25,964
+175
+0.7% +$22.1K
SYK icon
31
Stryker
SYK
$127B
$3.18M 1.06%
37,739
-825
-2% -$67.4K
VIG icon
32
Vanguard Dividend Appreciation ETF
VIG
$113B
$3.01M 1%
38,573
-100
-0.3% -$7.65K
ORCL icon
33
Oracle
ORCL
$435B
$3M 1%
74,052
-674
-0.9% -$27.7K
PFE icon
34
Pfizer
PFE
$159B
$2.98M 0.99%
105,809
+15,152
+17% +$432K
RDS.A
35
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.94M 0.98%
38,142
-696
-2% -$50.8K
CELG
36
DELISTED
Celgene Corp
CELG
$2.91M 0.97%
33,920
-800
-2% -$60.8K
AGU
37
DELISTED
Agrium
AGU
$2.87M 0.95%
31,297
+807
+3% +$74.9K
SJM icon
38
J.M. Smucker
SJM
$14.1B
$2.86M 0.95%
26,835
+3,710
+16% +$372K
DD
39
DELISTED
Du Pont De Nemours E I
DD
$2.86M 0.95%
46,017
+939
+2% +$60.3K
SLB icon
40
SLB Ltd
SLB
$85.1B
$2.76M 0.92%
23,401
+1,680
+8% +$173K
EBAY icon
41
eBay
EBAY
$47B
$2.71M 0.9%
128,717
+11,392
+10% +$248K
DVY icon
42
iShares Select Dividend ETF
DVY
$23.8B
$2.52M 0.84%
32,672
+1,309
+4% +$97.8K
PAYX icon
43
Paychex
PAYX
$45.2B
$2.48M 0.82%
59,731
-996
-2% -$40.9K
RTX icon
44
RTX Corp
RTX
$285B
$2.33M 0.77%
32,020
+953
+3% +$70.2K
CSX icon
45
CSX Corp
CSX
$95B
$2.31M 0.77%
225,090
-2,469
-1% -$24K
YUM icon
46
Yum! Brands
YUM
$42B
$2.21M 0.73%
37,780
-2,086
-5% -$116K
QQQ icon
47
Invesco QQQ Trust
QQQ
$489B
$2.13M 0.71%
22,715
+502
+2% +$44.8K
NVO
48
Novo Nordisk
NVO
$202B
$2.13M 0.71%
92,110
+650
+0.7% +$14.4K
TMO icon
49
Thermo Fisher Scientific
TMO
$230B
$2M 0.67%
16,995
-700
-4% -$82.4K
EMR icon
50
Emerson Electric
EMR
$86.6B
$1.88M 0.63%
28,350
+1
+0% +$67

Similar funds

J.W. Burns & Co's Q2 2014 Portfolio in Review

As of Q2 2014, J.W. Burns & Co held 160 positions worth $301M, up 6.7% from $282M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

J.W. Burns & Co's Q2 2014 filing shows 11 new, 64 increased, 59 reduced and 1 closed positions. Its largest new stake was Vanguard High Dividend Yield ETF: 15,474 shares worth $1.03M. The largest sale was Target, an estimated $724K.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Consumer Staples and Technology.

  • J.W. Burns & Co's largest Q2 2014 buy was Vanguard High Dividend Yield ETF: 15,474 shares worth $1.03M.
  • J.W. Burns & Co added most to Gilead Sciences in Q2 2014, an estimated $2.56M increase.
  • J.W. Burns & Co's biggest Q2 2014 reduction was Target, cutting an estimated $724K.
  • J.W. Burns & Co fully exited Frontier Communications Corp. in Q2 2014, selling an estimated $78K.
  • J.W. Burns & Co's ten largest holdings make up 30% of its $301M portfolio in Q2 2014.
  • J.W. Burns & Co opened 11 new positions and closed 1 in Q2 2014.
  • J.W. Burns & Co's portfolio value rose 6.7% quarter-over-quarter to $301M.

Based on J.W. Burns & Co's 13F filing for Q2 2014, filed 2 Jul 2014.